review with search terms including “miRNA” and “Type I and
Type 2 diabetes, GDM, preeclampsia, adipogenesis, obesity, and nonalcoholic
fatty liver disease” 13 (link),
18 (link)–33 (link) (
candidate miRNA abundance was measured via Multiplex Circulating miRNA assay
(Abcam, FirePlex, Cambridge, MA). Samples were digested and hybridized to miRNA
specific hydrogel particles with a universal biotinylated adapter labeled with a
fluorescent reporter, and quantified with EMD Millipore Guava 8HT flow
cytometer. Positive and negative controls were included to reduce inter-plate
and inter-well variability. MiRNA spike-in target probes measured hybridization
success. Blank hydrogel particles were run to define background fluorescence.
Abcam FirePlex Analysis Workbench software was used for data analysis (
Normalization was performed via geNorm algorithm using the three most stable
miRNAs across all samples (hsa-let-7d-5p, hsa-mir-107, and hsa-mir-342-3p)
34 35 . Data was log converted to
eliminate directional bias. Geometric mean and fold changes were calculated for
each miRNA based on normalized expression data.